Gummies Week · UP TO 75% OFF UP TO 75% OFF · Gummies Week Ends in This week only · 76 gummies picks marked down Shop the deals →
Go back
Refer for $20
$20
Refer
Get $20 in Chowcash when you refer friends, stores, and brands to Chow420. Your friends also get $20 towards their first purchase when they accept your invitation.
Login to Refer

Hemp News, Laws & Product Updates

A curated news hub focused on hemp regulation and policy changes, cannabinoids (CBD/Delta-8/Delta-9/hemp-derived THC), lab testing and COAs, product safety, brands, and industry trends.

  • Federal & State Hemp Laws
  • THC Policy
  • CBD / Delta-8
  • Compliance
  • Lab Testing (COA)
  • Product Safety
  • Industry & Brands
Back to Chow420
https://hightimes.com/

Vermont Senate Passes Legislation To Establish Psychedelic Working Group

Vermont is the latest state looking to further examine and embrace the potential of psychedelics, as the state Senate recently passed a measure to establish a working group to research psychedelics and confirm whether, and to what extent, they may be used in therapeutic settings. Senators approved the legislation, S. 114, on March 27, and it now heads to the House of Representatives for further consideration. Sen. Martine Gulick spoke to the potential of this research, given the growing body of literature finding that psychedelic compounds like psilocybin, found in “magic” mushrooms, could help to ease an array of mental health symptoms and conditions, including bipolar disorder, post-traumatic stress and other trauma-related disorders and more. Americans appear to be growing more supportive of psilocybin use for therapy as well, with nine in 10 finding its use to be “morally positive” in a recent survey. Additionally, other compounds like MDMA, LSD and ketamine have been shown to offer a number of potential mental health benefits. “Many would argue that these particular substances never should have been designated as Class One drugs to begin with because their power to heal far outweighs their ability to harm, especially when taken therapeutically with a doctor or health care practitioner,” Gulick said. Ahead of the bill’s second reading, Gulcik added that the legislation “will start the state of Vermont on a journey to explore other possibilities and other options to treating mental illness.” As it is currently written, the proposal would allow Vermont to establish an eight-member Psychedelic Therapy Advisory Working Group to examine psychedelic use as a means to improve physical and mental health.  The group would also make findings and recommendations “regarding the advisability of the establishment of a State program similar to other jurisdictions” allowing healthcare providers to  administer psychedelics in a therapeutic setting. The working group would also examine how legal access to psychedelics would impact public health. The working group would review current research on therapeutic use of psychedelic compounds, along with laws and programs introduced by other jurisdictions. Additionally, the group would be directed to seek out perspectives from individuals with lived experience on the therapeutic use of psychedelics and to provide “potential timelines for universal and equitable access to psychedelic assisted treatments.” The bill was originally introduced with provisions that would legalize use and possession of psilocybin, though the Senate Health and Welfare Committee decided to eliminate that section in March to focus on the working group explicitly. Sen. Ginny Lyons (D) suggested that decriminalization could “get in the way” of therapeutic use at the time, adding, “What we’re looking for is the value of therapeutic use.” While it’s still uncertain if the bill will ultimately pass, the effort represents a growing number of states looking to embrace new wave of psychedelic research and reform, largely with a focus on psilocybin. Denver, Colorado became the first city to decriminalize psilocybin in 2019, with the entire state of Colorado following suit in 2022. Oregon became the first state to both decriminalize psilocybin and legalize its supervised use in 2020. A number of U.S. cities including Oakland and Santa Cruz, California; Washington D.C.; Somerville, Cambridge and Northampton, Massachusetts; Seattle, Washington and Detroit, Michigan have similarly moved to decriminalize psilocybin in recent years. Looking at the current legislative session, psychedelic research and reform continues to be a popular focus.  Indiana Gov. Eric Holcomb recently signed a measure including provisions to fund clinical trials on the clinical benefits of psilocybin, while Utah Gov. Spencer Cox recently authorized a program allowing hospitals to administer psilocybin and MDMA as an alternative treatment option. Mirroring Vermont’s current effort, Maryland’s Senate and House of Delegates also enacted a measure that would create a task force to study possible regulatory frameworks for therapeutic access to psychedelic substances. Lawmakers in Vermont’s neighboring Connecticut are also considering legislation that would decriminalize psilocybin.  And this list is far from exhaustive, with plenty more efforts happening nationwide to continue exploring the potential of psychedelic compounds, lessen or eliminate criminal penalties and possibly increase accessibility.  Of course, it’s unclear what the road ahead holds, but if these trends persist, it’s likely to include increasingly more psychedelic research and reform across the nation.

https://hightimes.com/

Eastern Band of Cherokee Indians To Open First Dispensary in North Carolina

North Carolina-based Eastern Band of Cherokee Indians (EBCI) will officially be opening its cannabis dispensary on tribal land, effective as of April 20. This will also mark the opening of North Carolina’s first dispensary, since state legislators have not legalized medical cannabis. The EBCI tribe lies on 57,000 acres, called the Qualla Boundary. According to a press release published on March 25 by Qualla Enterprises, LLC, the company clarified that only medical cannabis patients will be able to purchase from the dispensary, called Great Smoky Cannabis Company. “With a commitment to quality, compassion, and education, Great Smoky Cannabis Co. aims to provide patients with safe and regulated access to medicinal cannabis products,” Qualla Enterprises wrote. “The new dispensary will open with high-quality tested products—including flower, vape products, edibles, topicals, and more—carefully curated to meet the diverse needs of patients. Product selection will continue to grow and evolve each month.” Only current medical cannabis cardholders (issued directly by the EBCI Cannabis Control Board) over 21 are permitted to purchase products once the dispensary opens. Qualla Enterprises added that out-of-state patients are welcome as well. “We will also extend reciprocity to individuals with out-of-state medical cards, or other tribal medical cannabis cards,” the press release stated. Medical cannabis card registration opened up in June 2023, and the first cards were issued starting in October 2023. At that time, 1,005 card applications were received, and the board had approved 817 of them. Great Smoky Cannabis Company is opening in a building that was once a bingo hall, not far from Harrah’s Cherokee Casino Resort. Currently, the product lineup includes dried flower, vape-related items, edibles, and topicals, although they plan to increase the selection over time. The Charlotte Observer was invited for a private tour of the dispensary in March 2023. At the time, Qualla Enterprises said that the dispensary would only be accessible to EBCI tribe members with approved medical cannabis cards. Eventually, patients throughout North Carolina with medical cannabis cards will be invited to shop at the dispensary. Qualla Enterprises’ early projections show that the Great Smoky Cannabis Company could collect up to $206 million in gross sales revenue during the first year of operation if they only limit sales to medical cannabis cardholders. If, or when, cannabis becomes available to adult-use consumers as well, the dispensary could collect an estimated $385 million. Projections from HedgeRow Analysis state that by the dispensary’s fifth year of operation, it could collect $578 million from medical cannabis patients, or $843 million if adult-use consumers are allowed to purchase. At a tribal council meeting, EBCI stated that approximately 1,400 people had applied for cannabis-related jobs (while only 350 openings were available at the time). Currently, the Great Smoky Cannabis Company only employs 69 people. In September 2023, the EBCI passed an adult-use cannabis referendum. Qualla Enterprises told The Charlotte Observer more recently that once the dispensary opens on April 20, it will only be available to those who hold patient cards first. Sometime in the near future, the dispensary will open up sales to more adult-use consumers. During that same month, the EBCI held a limited time three-hour open house, inviting tribe members to get a sneak peak of the dispensary. “It’s definitely surpassed what we were expecting,” said the dispensary’s plant health specialist, Jared Panther. “A lot of people are curious about what we’re doing, and a lot of people are coming out to show support for what we’re doing, what we love to do. We’re creating opportunity in a lot of ways.” Quall Enterprises chairperson, Carolyn West (who attended the dispensary sneak peak last year with her dog, Mr. Daniels), was thrilled about the tribe’s movement into the cannabis industry. “Qualla Enterprises acknowledges the Cherokee core values of maintaining their strong connection with the land and honoring their past,” West told The Charlotte Observer. She added the importance of honoring the Cherokee people’s use of cannabis as ancient medicine, and its inherent matrilineal society. “We have many females who work on the farm,” West explained. “They trim, they do production, they’re doing amazing work. I think they’re excited that we can possibly be making history, being the first tribe [and government] in North Carolina to legalize marijuana. And this product is safe, it’s tested, it’s going to be in child-proof containers, the safest means possible is what we’re doing here.” The EBCI legalized medical cannabis cultivation, sales, and consumption in August 2021. At the time, former EBCI principal Chief, Richard Sneed, explained the importance of providing tribe access to medical cannabis to treat conditions like cancer or chronic pain. “The Council’s approval of a medical marijuana ordinance is a testament to the changing attitudes toward legal marijuana and a recognition of the growing body of evidence that supports cannabis as medicine, particularly for those with debilitating conditions like cancer and chronic pain,” Sneed said.

https://hightimes.com/

A Cultural Love Story

For Alessandro Zecca and Danielle Duran-Zecca, a husband-and-wife team of culinary dynamos, the concept of romance language takes on many forms. It’s in their signature cuisine, “Mexitalian,” which merges Zecca’s Italian heritage with Danielle’s upbringing in Los Angeles as the child of Guadalajaran immigrants. It’s in their buzzy new LA restaurant, Amiga Amore, which serves up Mexitalian dishes in a cozy space created by the couple themselves. And it’s also in their shared love of cannabis and its incorporation into their fine-dining pop-ups.  Like so many love stories, this one started in New York City. “I went to culinary school in Pasadena at Le Cordon Bleu,” said Duran-Zecca. “The restaurant scene in LA wasn’t as booming as it is now, and I needed a change. I got an opportunity in New York City and bought a one-way ticket, sold everything but two suitcases, and went to go work at Le Bernardin to get Michelin star training.” After working in the famed French eatery for one year as a line cook, learning and elevating through the ranks, she landed a sous chef position at The Modern restaurant in The Museum of Modern Art in New York. Through that position, she met Zecca. “We had so much in common,” she said. “He was opening up a restaurant, and he was also on crutches. He had hurt himself and we ended up living like off of the same train. I helped him home… I was just a really nice girl.” Originally from Italy, Zecca had been working in New York as a restaurant manager. Having grown up in the kitchen of the restaurant where his mother worked her way from server to owner, he was ready to open a spot of his own. In 2009, he hired Duran-Zecca (at that time, just Duran) to be the chef of his first restaurant, Vespa, in New York. It thrived until an astronomical rent raise in 2017 forced the restaurant to close. “We had gotten everything out of New York and we wanted to start a family,” said Duran-Zecca. “We wanted to have a restaurant again of our own, and we just didn’t feel like we could get it again there.” The pair moved back to Duran-Zecca’s native Los Angeles and began hosting pop-ups around the city featuring a cuisine they dubbed “Mexitalian.” With dishes like huitlacoche cacio e pepe and chile Colorado cavatelli, Mexitalian merges their respective lineages in an unexpected way that reflects their many years in fine dining. The food is chic and delicious, with an air of whimsy as opposed to the pretense that often makes fine dining feel inaccessible. It was through these Mexitalian pop-ups that they linked up with Cannabis Supper Club, an LA-based cannabis dining collective, and started incorporating weed into their culinary experience. Before that, the frequent smokers had only dabbled with making edibles for friends, mainly using cannabis as medicine for themselves. “My relationship with the cannabis plant is strong and passionate,” said Zecca. “It lets my creativity flow and helps me relax when I need it most.”  “It’s my medicine,” said Duran-Zecca. “My family comes from a lot of mental health issues. They all have anxiety, bipolar, this and that. I just never wanted to take pills. But being a chef is a high-stress job. [Cannabis is] my relaxation. “When I got in touch with the Cannabis Supper Club, it mashed what I love to do outside of work, which is smoke, with my love for fine dining. We were delivering a higher, no pun intended, experience.” Their cannabis dinners are centered more on the idea of pairing cannabis with food, either with dabs and flower or by adding THC or CBD drops to dishes after they’re prepared, as opposed to infusing the food itself, which can be tricky when it comes to consistent dosing for large groups.  “We weren’t necessarily infusing the food, but we were pairing it like you would with wine,” Duran-Zecca said. “It was beautiful. The care that went into growing that flower is the same care that went into growing the farmers’ market mushrooms that I used, you know? And it wasn’t about getting faded or anything like that. No alcohol was served. All guests can partake in the cannabis aspect of the experience as much or as little as they please, then take the goodie bag home and experiment.”  After five years of running pop-ups around Los Angeles, gaining momentum behind their Mexitalian cuisine, the couple was able to open Amiga Amore, a brick-and-mortar Mexitalian restaurant, aptly near where Duran-Zecca grew up in Highland Park. “The restaurant has been a labor of love,” she said. “It used to be a jewelry store, so there was no kitchen. There was no bar. There were no water lines. We did a lot of work, and we did a lot of it to ourselves. “We’re really, really proud of it. It’s not the fanciest of restaurants, but it’s our aesthetic to feel like you’re in our home. The fancy part and the whole show come out on the plate. We want you to feel comfortable and homey and relaxed, then get wowed as the food starts to arrive.” As for what they’re looking forward to next?  “We’re just excited to keep being in our home, you know?” Duran-Zecca said. “I think we were a pop-up for so long that we got used to just always picking up and being on the move. It feels so nice that it is all here. I just come in and I turn on the lights.” Recipe by Amiga AmoreMakes 4 servings Ingredients: Broth: 2 apples (Granny Smith preferred)2 cucumbers (either 2 Persian or ½ hothouse variety, sliced into half-circles)1 serrano pepper¼ cup water½ cup lime juice Aguachile: 1 pound mahi-mahi (or any other fish you like and can slice thin)½ small red onion 6 radishes, sliced thin1 avocado, sliced thin1 bunch of cilantro1 jalapeño, sliced thin Method: To infuse, use a dropper to add CBD or THC to the liquid broth: 5 mg THC to start (add more if needed)10 mg CBD to start (add more if needed) This article was originally published in the March 2024 issue of High Times Magazine.

https://hightimes.com/

Prepared to Fail

Comedian Stavros Halkias is ready to chill the fuck out. After blazing through the comedy scene over the past year—self-producing his debut comedy special, Live At The Lodge Room, and recently dropping his first Netflix special, Fat Rascal, just over a year later—the New York-based comedian hailing from Baltimore is ready to finally rest for a minute. “I’m tired of hotel rooms and Delta lounges,” Halkias said during a recent phone conversation. “I’m looking forward to sitting on my couch, smoking weed, and just zoning out for a couple of months.” It’s a well-deserved respite for a man who’s been in the spotlight seemingly overnight. But a look under the hood reveals Halkias has been hitting the road hard in preparation for his first Netflix special—shooting it less than a year after Lodge Room dropped—while simultaneously continuing with his podcast Stavvy’s World and writing and shooting an indie movie Let’s Start A Cult which is expected to drop this year. Throughout our conversation, Halkias opened up on his path to success, his relationship with weed, and how thinking he wasn’t going to “make it” helped his comedy career unfold in a fun, organic way that ultimately led to success. High Times Magazine: Growing up in Baltimore, was pursuing comedy always the goal? Stavros Halkias: It was a weird thing because, in the back of my head, I knew I always wanted to pursue comedy, but it was this forbidden thing because I’m the firstborn son in an immigrant family. I was good at school. I went to school on scholarship, and everyone expected me to become a lawyer or something. Comedy was something I could never fully admit to openly but was something I knew I wanted to get into. My freshman year of college, there was an open mic night in the basement of my dorm, so I decided to try stand-up for the first time. It was a very friendly crowd, and it became sort of this secret thing. I don’t want to equate it to being in the closet—obviously, being queer in the closet is much harder, and I’m not saying it affected my life in a negative way—but it did feel like I was living with a secret that I didn’t want my parents to find out about. I knew it had to come out eventually, and I was always trying to find acceptable ways to flex that funny talent and desire. You knew innately your calling, but because of external factors—namely your parents—you were stuck in the comedy closet. I was, man. I really was. I was a lot funnier to be around when I didn’t have comedy because you’re trying to prove you’re funny and flex that muscle. I was always joking around in school and fucking with people—which is also a product of going to Baltimore City Public Schools—where you kind of have to roast for your life. You have to roast to make sure you’re not getting mocked, especially when you’re a fat kid—which I’ve been my entire life and have been pretty comfortable with. Humor is also a classic deflecting device and is a good way to endear yourself to people, so while I couldn’t admit that comedy was what I wanted to pursue, it was my strongest social asset when I was a little kid. What helped you eventually embrace comedy as part of your identity? My buddy Eldis Sula—producer of my podcast Stavvy’s World and my tour manager—is my best friend, who I met in kindergarten. He’s a very funny guy—even though he’s not a performer—and I used to run all my jokes by him. I remember doing that first open mic and then crashing Eldis’s apartment to do open mics in College Park, D.C. It was literally freshman year of college when I was no longer in my family environment, away from those pressures and expectations. In the same way, kids experiment with all kinds of shit in college; it was the same for me and comedy. The second I stopped living with immigrant guilt, I was like, “Fuck it, let’s do this.” Was the validation from friends and peers for being funny the thing that gave you the confidence to keep going? It’s not even a matter of confidence. I just don’t feel I ever wanted to do anything else. I remember doing open mics, being like, “Hey, if nothing happens from this, I will do open mics my whole life.” That’s what I thought when I was 22. You can think that when you’re 22, but it’s a different story if you’re fucking 40 and you have kids, and you’re missing soccer practice because you’re bombing at an open mic. I never thought about “what could go wrong,” and really, I was just prepared to fail. I just assumed it wasn’t going to work out. My craziest goals were to headline really shitty clubs—I just wanted to find really shitty places to perform. I never really thought about my career, never cared about what was going to happen, and I got very lucky that when the time came to start thinking about that stuff, my career started to do well. While I’ve never come face to face with some kind of “needing confidence” moment, I did quit comedy after doing it at 19 for two years. Two years after starting, all that immigrant guilt came back. I fully quit comedy for a year and a half and dedicated myself to studying. I was in the public policy scholarship program, and I interned in the Maryland House of Delegates and was getting my resume together. I even went to therapy to try and work through my guilt issues. But I was so miserable for those 18 months that it was so clear I had to do shitty open mics. I was so depressed from trying not to be a comedian that I committed myself to comedy—with the idea that if it ever made me as equally depressed—I’d find something else to do. Now you’ve got your special Fat Rascal out on Netflix. How did your journey so far culminate with this material and what’s the inspiration behind it? I’m really proud of the hour. I worked really hard on it, and it really is the culmination of all of these different things. After going on tour with Bobby Kelly, I was doing a podcast with Adam Friedland and Nick Mullen called Cum Town, and we started making money on it, which is where I had my first taste of a fanbase. So, as that grew, I started to post videos online, which became an online fanbase. That then powered ticket sales, which then helped power my first self-produced special, Live At The Lodge Room, which got over six million views [on YouTube]. Suddenly, I had all this attention from all of these different sources. I had planned to take some time off, but for the first time, I had a real demand. So, instead of taking time off, I stayed on the road that entire year and ended up developing a new hour faster than I’d anticipated. I thought, “Could I potentially get a Netflix special?” It felt crazy and farfetched, but I wanted to try for it—and if it seemed possible—I’d do it. It was like, “Fuck taking a year off, this could change my life.” I felt I had the opportunity to work on some cool shit, and you don’t get a lot of those chances. We put the pedal to the medal, and to my surprise, everything worked out. The flipside to that, though, was that I then had to do everything. The material for Fat Rascal was really forged in the chaos of things popping for me and me trying to seize the moment—doing eight-show weekends so I could really hammer the material home while also doing a bunch of other stuff. A lot of it is about me giving into my vices—the portrait of a guy who’s all over the place, a little scatter-brained, traveling constantly, disconnected emotionally—who’s not doing great but is still trying to keep it together and make the special. It’s like a child born out of a dysfunctional family that you’re really hoping will grow up to be an honors student. That’s what this special is. Having said that, I’m really proud of it and I think the kid’s really smart—I think he’s really got somethin’ [laughs]. What role—if any—did cannabis play in your process? A very prominent one. I’m a huge edibles guy, with weed being my biggest issue. They say there’s no weed addicts, but it’s pretty fucking good as far as I’m concerned. I love getting high constantly, and it was the kind of thing where I was having too good a time. Still, when I’m stressed, the thing I like most is decompressing with a joint—even more so than pills or a couple of drinks. The ritual of a joint before bed is awesome, but that ritual turned into 50 milligrams before bed and getting Ben & Jerry’s. I could tell when I was getting serious because I was like, “Alright, weed’s gotta go for a second [laughs]. You know what I mean? I gotta lock up my friend and see him after all this work gets done.” Food, weed, and girls—or just trying to have sex—is the best time in the world for me. Getting high with a pretty girl, splitting a fucking pint of Ben & Jerry’s—that’s the dream, baby. Does it aid your creativity, or is your consumption mainly to reduce stress? Weed is more of a good time for me, but when it hits in that creative zone, it feels great. If I smoke early in the day, don’t overdo it, and pair it with a coffee or ADHD meds—I’m in the fucking zone. My problem is I like it too much, and I think, “If I feel this good right now, why don’t I smoke even more? [laughs]” And then it’s like, “Fuck it, we’re watching Chuck Norris movies instead of working the rest of the day.” This article was originally published in the March 2024 issue of High Times Magazine.

https://hightimes.com/

Are Fake Psychedelics the New Gas Station Boner Pills?

A few months ago, a popular CBD brand wanted to send me some of their new “psychedelic mushroom” gummies. I assumed they were microdosed with psilocybin from actual mushrooms. Lots of psilo products are sold online. It didn’t strike me as odd. The package arrived looking like it was from the glory days of cannabis media when the money was still flowing. A giant box of lacquered cardboard opened to a rainbow display of products, swag objects, and sparkly crinkle-cut packing paper. Wow, I thought. They’ve got money.  PR packages that cost more than the products they tout have become rare in this economy. I tend to view them as a red flag that you’re dealing with a brand whose profit margins are high because the quality of their products is low. Or they have a ton of VC money, another indicator the drugs probably suck.  I picked up the gummies in question. An iridescent mylar bag boldly read “entheogens” one too many times. The rest of the packaging was a clusterfuck of buzzy words that can mean anything you want them to, like “magic” “nootropic,” “proprietary blend,” “micro,” and finally, in tiny font in the far corner of the ingredients list, “muscimol.”  A quick Google search told me that muscimol was one of the active ingredients in amanita mushrooms. So, why didn’t they just say that? Sus. I ate a couple anyway (for journalism) and drove to a meadow where I enjoy being high.  My first intimation they had taken effect was a soft gnaw of existential dread. I found myself on a windy day in a field of wildflowers, ensconced in physical anxiety. The colors were vibrant and I was high, but in a strange, wobbly way that made me question my safety.  Psychedelic nature jaunts usually leave me musing as all the pieces of existence fit together like a cosmic zipper. This felt more like sitting in front of a static television I couldn’t turn off.  As opposed to the life-affirming aspect of the psychedelic experience that makes tripping ultimately positive, these gummies left me wondering, what the fuck did I just take? Probably not anything that came from an amanita mushroom, it turns out.  “Amanita Muscaria is mycorrhizal, meaning they grow by forming symbiotic relationships with tree roots,” my friend Chris from the fruiting body brand Humboldt Fungi DMed me after I posted about the experience. “You can’t grow amanita. They have to be wildly harvested, and the window to do that is very short.” He continued, “It would be hard for me to forage enough to create an amanita extract for a small run of products. For a big brand to create enough amanita extract to release an endless amount of products online and to every smoke shop in the world at one time is impossible.”  Synthetic research chemicals being sold as “entheogens,” or misrepresented as naturally occurring plant chemicals has become a rampant issue. Born from a combination of greed, noob consumers, and bad policy, these legal mystery drugs are an out-of-control train that can’t be stopped. Similar to the wave of chemically altered cannabinoids ravaging the cannabis industry, these synthetic psychedelics are the Delta-8s and hemp-derived Delta-9s of the mushroom world. They’re found on the internet and IRL, everywhere from the gas station to the head shop and illegal dispensaries.  The market for these products is unregulated, and not subject to testing. The tests they do have are from unregulated labs, meaning the results can be manipulated or fabricated, and there’s no way to know what is in any of this shit.  A recent study by DoubleBlind Magazine purchased an array of these “psychedelic” products and had them tested independently. Most contained no psilocybin or amanita, instead testing for substances like 4-AcO-DMT, a research chemical that converts to psilocin once ingested, causing you to trip out but not how you intended.  The moral implication of selling newbies a psychedelic experience in the form of a corn syrup cube that drugs them with mystery chemicals is, at best, terrible. There’s also the issue of consent at play. You can’t consent to take a drug that you don’t even know you are taking.   To be clear, my issue isn’t with synthetic drugs. Lots of synthetic drugs rule. LSD, MDMA, and even Ketamine have shaped modern counterculture. I also see the value in synthetics that supplement problematic substances like 5-MeO-DMT, as reaching personal enlightenment on a mass scale through the decimation of an entire species of toad is, in fact, low vibe. But I don’t fuck with synthetic drugs created solely for profit or to slip through regulatory loopholes. These are not lighting bolt chemicals like LSD. These are sloppy, dangerous, and designed to do a shitty job of imitating the experience of a superior substance. It’s especially offensive when they’re calling themselves entheogens, which are naturally occurring gifts from nature used for millennia to commune with higher powers. One of the many reasons that capitalism and psychedelics don’t mix is that big business is never going to sell you good drugs.   Head shop drugs have always sucked, and charlatans have been rebranding chemicals as plant medicines to sell legally for as long as I can remember. When we were kids, it was salvia and spice. This is not a new game.  I don’t know if any of those products contained the substances they said they did, or if it was another case of chemicals being sprayed on shit and consumed by people who didn’t know any better. From fake psychedelics and D-8 to spray packs, that hustle is still booming and will continue to boom quite possibly forever.  Newbies don’t have access to good drugs. They never did, and they still don’t. Drug culture is a sub-culture. You can’t buy your way in. The more you engage with the culture, the more it rewards you. The deeper you go, the better the drugs.  The cool thing about legitimate psilocybin brands coming onto the market is that they are making high-quality psychedelic experiences available to more newbies than ever before.  These fake mushroom brands are specifically fucked up for convoluting the fledgling market by tricking nervous consumers into having bad experiences they’ll forever blame on the very entheogens that could’ve helped them.  But the truth is, we should know better. Just because these flashy new products have cute branding and are sold in places that don’t seem sketchy doesn’t make them any different from the trash drugs that have always been sold legally.  We must stay vigilant and uncompromising in categorizing fake entheogens, fake cannabinoids, and all otherwise offensively bad knock-off drugs as gas station boner pills until further notice.  Just say NO. 

https://hightimes.com/

Researchers Find New Way To Measure Potency of Mushrooms

A new technique has arrived that measures the potency of psilocybin and psilocin, great news for those medicated by mushrooms.  Credit goes to teams at the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments in Maryland, and Millipore-Sigma in Round Rock, Texas. They comprise the brilliant minds behind the method for quantifying the potency of psilocybin and psilocin in magic mushrooms, known in the medical and scientific community as Psilocybe Cubensis. “These legislative changes are expected to facilitate further research and potential clinical applications,” stated Kevin Schug, the Shimadzu Distinguished Professor of Analytical Chemistry in the Department of Chemistry and Biochemistry. Psilocybin is not a psychoactive compound. Psilocin, however, has a strong relationship to our 5-HT receptors, which are responsible for the infamous psychoactive effects.  Schug and the team’s discovery was originally published in a recent issue of Analytica Chimica Acta, breaking down the experimentation and final results. It took ten authors to explain the results, including Sabrina Islam, Sue Sisly, and Arun Babu Kumar, among other significant team members behind the breakthrough in testing. Here’s how they did it: utilizing liquid chromatography (LC) with tandem mass spectrometry (MS/MS), they extracted and measured the potency of the mushrooms. For those without a scientific background in the audience, liquid chromatography separates molecules. As for tandem mass spectrometry, it dissects ions into fragments and reveals the chemical structure. By combining these two techniques, the researchers studied five strains of dried, intact mushrooms: Blue Meanie, Creeper, B-Plus, Texas Yellow, and Thai Cubensis. (Familiar names to mushroom aficionados, no doubt.) The study found that the average total concentrations of psilocybin and psilocin for the Creeper, Blue Meanie, B+, Texas Yellow, and Thai Cubensis strains were 1.36, 1.221, 1.134, 1.103, and 0.879%. The entire process is surprisingly described as “relatively low-cost,” which inspires hope for present and future clinics and patients. The revelatory results were cross-referenced in two separate labs, including a non-affiliated lab, to confirm accuracy. “As medical professionals identify more safe and effective treatments using mushrooms, it will be important to ensure product safety, identify regulatory benchmarks, and determine appropriate dosing,” Schug added about the discovery. “Established and reliable analytical methods like the one we describe will be essential to these efforts to use mushrooms in clinical settings.” Now, time for a bit (or A LOT) of history. Mushrooms grow in mundane substrates such as dung, mosses, soil, and wood. They can flourish in various conditions. Consider it a part of their magic. Among the hundreds of species in the Psilocybe genus, the popular kid is P. Cubensis. Growing kits for P. Cubensis are commercially available, even if they are sadly illegal in many states. At their best, Psilocybe Cubensis and other magical mushrooms can induce perceptual distortions, mood alterations, mystical experiences, and euphoria. Under the right circumstances and perhaps with the right group of people, they not only provide a good time but an enlightening one that makes you and the world around you glow (aka a “serotonergic psychedelic”). For thousands of years, they’ve been ingested and appreciated, all the way back to indigenous tribes and civilizations. Of course, to this day, magical mushrooms are ingested in ceremonies for religious and spiritual purposes. Or, in most cases, just to have a damn good, mind-expanding time.  In 1970, Uncle Sam attempted to kill the party and curb the mushroom fun, as well as the mushroom healing. The anti-hippie President Richard Nixon and his famously corrupt administration passed the Controlled Substances Act. Nixon, a devilish general of sorts in the war on drugs, made the possession of psilocybin and psilocin illegal. Mushrooms were classified as Schedule 1 substances. In the Act’s own, outdated words, a Schedule 1 drug is essentially one with “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” Due to government restrictions, research on shrooms slowed down significantly. Not much support was ever there for it; researching Schedule 1 drugs in the United States necessitates registration and licensure by the Drug Enforcement Administration. Not an easy task, basically. It was a topic of importance that went undiscussed in the ‘70s, but eventually, the truth came into the light: mushrooms are viable medical treatments.  The beautiful drug’s legal status continues to evolve, albeit at a slower than desired pace. Oregon – which was the first state to decriminalize cannabis in 1973 – became the first U.S. state to legalize the federally illegal psilocybin-assisted therapy. Since then, Colorado has also decriminalized the possession of magic mushrooms. As a result, more research and potential clinical applications have been pursued and produced groundbreaking developments, such as the new technique to measure potency, that will continue to improve and even save lives, thanks to all the advocates and researchers involved. 

https://hightimes.com/

Republican Senators Say Cannabis Rescheduling Violates International Treaties

Senator Mitt Romney of Utah and two of his Republican colleagues have sent a letter to the Drug Enforcement Administration, urging the law enforcement agency to decline a bid to reschedule marijuana under federal drug laws. Cannabis is currently listed under Schedule I of the federal Controlled Substances Act (CSA), a designation reserved for drugs with no accepted medical value and a high potential for abuse. The letter, which was signed by Romney and Republican Senator Jim Risch of Idaho and Nebraska’s Senator Pete Ricketts, was addressed to Drug Enforcement Administrator Anne Milgram. All three lawmakers are members of the Senate Foreign Relations Committee. In the letter, the senators expressed concerns over a Biden administration proposal to reclassify cannabis under the CSA.  In August 2023, the Department of Health and Human Services (HHS) recommended that the DEA reclassify marijuana by moving it from Schedule I of the CSA to Schedule III, a classification intended for “drugs with a moderate to low potential for physical and psychological dependence” such as Tylenol with codeine or ketamine. The trio of Republican senators urged the DEA administer to carefully consider the HHS proposal. “Any effort to reschedule marijuana must be based on proven facts and scientific evidence — not the favored policy of a particular administration — and account for our treaty obligations,” the senators wrote in their letter. The senators noted in their letter that cannabis is controlled by international treaty, “which is not surprising given its known dangers and health risks — and the United Nations International Narcotics Control Board (INCB) has fiercely criticized efforts to legalize marijuana in other countries as a violation of the treaty.” International policy on marijuana is governed by the Single Convention on Narcotic Drugs, an international treaty adopted in 1961 and ratified by the U.S. Senate in 1967. Under the treaty, the United States is required to implement certain controls over drugs covered by the international agreement, including marijuana. The CSA implements those treaty obligations in U.S. domestic law and requires the U.S. Attorney General to place marijuana in the schedule that he or she deems most appropriate to carry out the country’s obligations under the Single Convention. “In prior rescheduling proceedings, the DEA has determined that section 811(d) requires it to classify marijuana as a schedule I or II drug in order to comply with our treaty obligations under the Single Convention,” the letter continued, referring to the relevant section of the international treaty. “It is important that the DEA continues to follow the law and abide by our treaty commitments,” the senators wrote.  The senators also requested more information including whether rescheduling marijuana would affect whether other countries comply with drug treaty provisions “including for deadly narcotics like fentanyl,” asking the agency to respond to a list of questions by April 12. The letter also cites a recent study that showed that daily marijuana use was associated with a 25% increase in the risk of a heart attack and a 42% increase in the risk of stroke. They also noted that other research has linked cannabis use “with serious psychotic consequences, including schizophrenia and bipolar disorder.” On Wednesday morning, Romney took to social media to share the letter he and his Republican colleagues sent to Biden administration officials at the DEA. “To be blunt: rescheduling marijuana may cause the U.S. to violate obligations under the Single Convention on Narcotic Drugs,” Romney wrote on X, the social media platform formerly known as Twitter. “Efforts to reschedule marijuana must be based on evidence, not politics, and @DEAhq must ensure we abide by our treaty commitments.” Despite the senators’ fears, Jason Adelstone, a senior associate attorney with national cannabis law firm Vicente LLP, said that international treaties do not preclude the federal government from reclassifying cannabis under Schedule III of the CSA. “The erroneous and unsubstantiated fears about marijuana are based on fictional ‘war on drugs’ themes and not the current state of medical and scientific knowledge about marijuana,” he wrote in an email to High Times. “The letter contained several incorrect statements, including the mistaken assumption that moving marijuana to Schedule III would somehow violate the Single Convention.” “However, the Single Convention specifically endorses ensuring medical and scientific access to controlled substances,” Adelstone continued. “Moving marijuana to Schedule III would better promote medical and scientific access to marijuana.” The DEA is currently reviewing the HHS proposal to reschedule marijuana, but the agency has not announced a timeline for the decision.

https://hightimes.com/

Cannabeginners: What is Humulene?

Humulene is one of the predominant terpenes in Humulus lupulus, the common hops, from which it derives its name. As hops and cannabis are plant cousins, it should come as no surprise that humulene is also one of the most common terpenes in cannabis. Like beta-caryophyllene, alpha-humulene (or humulene) is a sesquiterpene, but it does not have the cyclobutane ring which makes caryophyllene stand out from other terpenes. Due to how frequently they are found together, in the past humulene was referred to as alpha-caryophyllene, but it is a substantially different terpene with its own medical effects. While beta-caryophyllene has been identified as a dietary cannabinoid, humulene has so far not been given that same status.  As the core ingredient in heavily hopped beers, like India Pale Ales, hops is usually described as having a bitter or “hoppy” flavor, which isn’t terribly helpful for anyone who hasn’t had an IPA. What is meant by bitter and hoppy is that the flavor is herbal, woody, or spicy, similar to the scents and flavors of the ginseng, sage, and cannabis plants where it also is commonly found.  It is important to note, that despite humulene (a terpene) having a very similar name to “humulone,” they are very different chemicals, and humulone is not a terpene but actually a form of lupulic acid found in hops. If you are researching studies on humulene you should be certain that the studies you are looking at are on humulene and not humulone.  Despite IPAs having “India” in their name, they were first brewed in England and originally called barleywine, the name became IPA when the British Indian army began to import it to India. While today, barleywine is a distinctly different style of beer with a higher alcohol content and sweeter flavor than most IPAs, what they have in common is a huge amount of hops, thus, humulene. Some of the original IPAs were brewed with “up to 10 pounds [of hops] per barrel.” The main reason for hops in beer is that it acts as a preservative, and as the main terpene in hops (up to 52% of the terpenes), humulene plays a huge part in those effects. In addition to having a high amount of humulene, most hops cultivars also have a significant amount of caryophyllene and myrcene. Like cannabis, there can be a wide range of flavors for different types of hops, from the sweet citrus Citra hops, to bitter cultivars like Chinook. Given the strong genetic links between hops and cannabis, the overlap in terpenes shouldn’t be a shocker. The similarities go even deeper than that, as both cannabis and hops have resinous glands (either trichomes in cannabis, or lupulin glands in hops). This explains why many beer brewers and top craft breweries have been working on creating cannabis-infused beer, either with just terpenes, or in some cases cannabinoids as well.  Despite humulene being one of the major terpenes in cannabis, the overall percentage can be quite low. In one older study, researchers found that just 0.7-6.7% of the terpenes in cannabis samples was humulene. In a 2018 study, the percentage of humulene was found to be as low as 11% to potentially as high as 27%, significantly more than in previous research. Generally speaking, plants have terpenes because they offer some kind of defense or benefit to the plant, and humulene is no exception. Multiple studies have shown humulene to have insecticidal effects in a variety of plants, including “paralysis and muscle contractions … which indicates neurotoxic effects,” and it displays a “deterrent effect” against the yellow fever mosquito. Presumably, humulene plays a similar role in cannabis and hops, fending off predatory insects.  Pain is one of the major conditions people turn to cannabis for, and humulene is one of the chemicals that plays a role in those pain relieving effects. Research has shown it to be an “effective analgesic when taken topically, orally, or by aerosol.” Multiple studies have found humulene to possess anti-inflammatory properties when taken topically, orally, and by aerosol. In one study, humulene was found to have anti-inflammatory effects comparable to the drug dexamethasone. Just like humulene can protect plants from insects, it can help protect your body from bacteria. Despite humulene being a relatively minor constituent of balsam fir oil, it was found to be one of three terpenes in that oil with an effect against Staphylococcus aureus bacteria. In a 2020 study on humulene researchers noted it was also effective against enterotoxigenic Bacteroides fragilis, which can cause inflammatory bowel disease and colorectal cancer. Beyond helping prevent a potential cause of colorectal cancer, humulene has demonstrated anti-cancer properties for a range of other cancers. In another study looking at balsam fir oil, humulene was observed to have dose-dependent antitumor effects through multiple mechanisms of action. A different study on humulene and cancer found its antiproliferative activities to be “significant,” and also that it possessed no binding properties for the CB2 receptor. Finally, caryophyllene has been shown to “significantly increase the anticancer activity of alpha-humulene.” Humulene is one of the main terpenes found in both cannabis and hops, giving them a woody, spicy, or herbal flavor. In addition to giving IPAs their characteristic flavor, humulene has a number of medical benefits including antibacterial and anticancer properties.

https://hightimes.com/

Pew Survey Finds 9 in 10 Americans Support Pot Legalization

Thinking back just 10 years ago, the previous U.S. cannabis landscape stood in stark contrast to the one we enjoy today. The United States currently has 38 states with legal medical or recreational cannabis, with 74% of Americans living in a legal cannabis state and 79% living in a county with at least one cannabis dispensary.  With nearly 15,000 dispensaries throughout the nation, retail cannabis stores now outnumber the roughly 13,500 McDonald’s locations in the country. Given the prevalence of legal cannabis throughout the nation, and as reform becomes a prominent political talking point among state lawmakers and even in the executive branch, it’s perhaps unsurprising that American attitudes surrounding cannabis legalization have become overwhelmingly supportive over the years. Pew Research Center has consistently monitored this progression, with its most recent report affirming that U.S. citizens are indeed incredibly supportive of legal cannabis. The survey was conducted Jan. 16-21, 2024 among 5,140 adult participants. Nearly nine in 10 U.S. Americans (88%) said that cannabis should be legal for medical or recreational use, and a majority (57%) said that they believe cannabis should be legal for both medical and recreational purposes. About a third (32%) said that cannabis should only be legal for medical use, while just 11% of respondents said that cannabis should not be legal whatsoever. The survey also took a closer look at American attitudes surrounding the impacts of legalization, with 52% saying it’s good for local economies (17% said it is bad while 29% said it has no impact). Respondents were also asked about reform’s impact on the criminal justice system, with 42% saying that legalizing recreational cannabis results in more fairness (18% said recreational legalization makes criminal justice less fair and 38% said it has no impact). American views were more mixed when it came to recreational cannabis legalization and some of the more negative potential implications. Around the same amount of respondents said that adult-use cannabis legalization increases (29%) or decreases (27%) the use of other drugs (42% said it has no impact), and more Americans viewed recreational cannabis legalization as creating less safety (34%) for communities over more (21%), with the majority (44%) saying that it does not have an impact on community safety. While cannabis reform has steadily gained more bipartisan support over time, the survey shows that Democrats and Democrat-leaning independents still tend to show more support than their Republican counterparts. Democrats largely believe that recreational cannabis is good for local economies (64%) and makes the criminal justice system more fair (58%), while fewer Republicans said the same (41% and 27%, respectively). Consequently, Republican respondents tended to cite the negative potential impacts of cannabis reform more than Democrats, with 42% saying it increases the use of other drugs (compared to 17% of Democrats) and 48% saying it makes communities less safe (compared to 21% of Democrats who said the same). While the long-term impacts of cannabis reform are still being studied, it should be noted that numerous studies have debunked the assertion that cannabis reform encourages the use of other drugs. Similarly, studies have shown cannabis legalization is not associated with an uptick in car crashes, a rise in use among youth or youth perceptions of cannabis. Looking closer at other demographics, Pew echoes myriad other studies and surveys finding that older adults are far less likely than younger adults to support cannabis legalization. Pew reported similar trends when it came to attitudes around the impacts of cannabis legalization, with younger respondents far more likely to report that cannabis is good for local economies and makes the criminal justice system more fair. The polling is largely consistent with Pew’s previous reports. The 2022 survey also reported that 88% of American adults supported legal medical or recreational cannabis, with 10% stating cannabis use should not be legal at all. Speaking to the survey results, Paul Armentano, deputy director for the National Organization for the Reform of Marijuana Laws (NORML) advocacy group, said that the increasing support can be linked to a lack of “buyer’s remorse” surrounding cannabis legalization among voters. “As more states have adopted legalization, public support for this policy has risen dramatically,” Armentano said. “That’s because these policies are largely working as intended and because voters prefer legalization and regulation over the failed policy of cannabis prohibition. Elected officials who refuse to take action to end cannabis criminalization do so at their own political peril.”

https://hightimes.com/

Jon’s Stone-Cold Cop List #48: Americans in Spain

It feels like it’s only been a week since I wrote the last one of these, but March has already come and gone and I haven’t stopped moving long enough to catch my breath. From art shows to weed bros, this month was packed to the gills with fun events (I have a problem overbooking) and we haven’t even gotten into the 4/20 madness yet! Well that’s not entirely true, there’s madness in my inbox, but if I don’t read the pitches it’s like they’re not there, right? Anyway, I’ve got a piece coming in the next few days about my experience at The Chambers Project’s Godfathers show earlier this month, but I’m going to include all my highlights from the Spannabis trip here as Barcelona was a literal blur and I am still barely remembering what day it is. That will be the latter half as there’s some local heat that requires call outs, but shouts to all the homies I spent time with out there, and to all the gracious hospitality – there are far too many of you to name but I love you nonetheless. Let’s do it again sometime somewhere… chiller. As always, don’t hesitate to reach out to let me know what I missed, or what needs to be on the next one.  One of my favorite of the new school cultivators, Life Is Not Grape has some incredible new heat on his hands. Over the past few weeks I’ve found myself coming back to his new gear nearly every time I’m ready to sesh. The new offering includes 99Z, a cross of his fan-favorite 996 with competition-sweetheart Zkittlez that was bred by nineweeksharvest, as well as Sad Candy, which is Bolo into Papaya. And while these are clearly sweet smokes, each has more than enough gas for even OG smokers. The 99Z in particular is a versatile high, with an energizing and creative peak that can quickly lay you out if you overindulge. I love to walk that line. Most of my mentions of Team Elite in the past have been around the new heat they’ve shown me at Hall of Flowers, and while I wasn’t able to make the first show of the year this time, I did catch up with the Team in LA before I left for Spain. As I’ve become accustomed to with these guys, their latest cultivars are unlike anything else on the market – pushing daytime varietals and unique terps like styrofoam and cheese in a big way right now, which is a great zig on the overextended candy gas zag the market’s making right now.  If you’ve caught yourself recently reminiscing on the bud from back in the “good ‘ol days”, you should check out what Heirbloom’s got cooking. Brought to you by Cannabiotix, one of the leading brands (by just about every measure) in California’s recreational market, Heirbloom is a new label running a suite of classic cultivars that are frankly even better than I remember, which is nearly impossible to do with nostalgia plays. Strains like Cherry Pie, Sherbert, Orange Crush and Green Crack are almost brand new, as grown with todays best practices the flowers are checking all the modern boxes while still getting you high school high. A true testament to the classics! Speaking of classics, I ran into the No Till Kings a few weeks back, and they brought me a jar of Durban – one of my all time favorites – that sent me through a time warp back to my teens. Alongside Sensi Star, this was one of the strains that got me through college, and it’s still that morning rocket fuel I remember. I talk a lot about needing solid daytime smoke, and Durban Poison has been a staple longer than I’ve been alive, so it’s good to see the gang doing justice by one of our OG’s. These guys are three for three with telling me they’ve got some insane new heat and it actually living up to the standard they set, and let me just say, even most of the kings aren’t that accurate. Their latest, 11 Coffins, is a cross between hypebeast RS-11 and the cultivar I mentioned in their last cop list appearance, Coffin Candy. If you’re an LCG fan, which, going by the numbers seems to be an awful lot of you, here’s a familiar yet different taste I think you’ll dig. This one’s a bit stonier on the high – great for when you’re trying to relax, so although it tastes so sweet you’ll expect a sugar high; maybe save this one for the evenings. I’ve written about Heady Heads before, and while I’ve said in the past they make the best monster sized prerolls in the game, each of the past few times I’ve seen them in the wild they’ve been pushing a new product, expanding the brand in a rapid clip. I’ve seen a bunch of their flower now, which was all impressive by any standard, but their massive eighth sized joints – now available as hash holes – still just absolutely steal the show. In fact, now that they’re making holes someone has finally usurped my long standing king of the preroll market – which is just them replacing themselves. Out of all the social clubs I went to in Barcelona, without question the most comfortable of the lot was HQ. Now certainly Spannabis week is much busier than normal for any of these clubs, but even packed HQ wasn’t as overwhelming as some of the other spots I visited. There was ample seating, with tables, and plenty of drinks and snacks on offer, but they also did a killer job with decorations. I mean, what other consumption lounge has custom Talking Terps artwork adorning their walls? None that I know of! It’s worth noting this was one of the pricier establishments, with a EUR 50 annual membership fee, but everything else is pretty fairly priced once you’re inside. And for locals that $50 doesn’t hurt quite as much, as they get a full year, instead of only the week I was visiting. Out of all the flower I saw while over in Barcelona, would you believe my favorite come up from out there was from California? Go figure. I ran into Hall of Flame during my one day on the actual Spannabis show floor, and boy did this make up for some of the other samples I was shown that day. This was my first time hearing of Hall of Flame, and I’m glad to report that with a name that bold, the flower actually stacks up – and real bright green weed, at that! I will definitely be keeping my eye out for these guys now that I’m back home. Now for the best Spanish cultivated flower I saw. This was my first experience with Bando Farmers, and I’ve got to say their buds were far superior to what I expected the local wares to look like. This super orange forward cultivar was plenty picturesque, but it was the flavor that stopped me in my tracks. Supplied by the homie Fran from Terpy, this one would be a killer in any city in the world. It was the first local smoke that I actually felt REALLY high from, and I didn’t even throw any hash inside it. Considering the surplus of material I was working with that week, smoking a single flavor stick meant something. It’s worth noting, this one was also bred by Julio (nineweeksharvest), so if you’re looking for outstanding genetics… Speaking of Terpy, these guys deserve their own mention as well. Another one of my favorite clubs out there, what Terpy lacks in size it makes up for in vibes. Completely decked out in the brand’s bright yellow, everyone from the employees to the patrons just seem to have a great time there, it’s an almost bubbly atmosphere. Shouts out to Fran and Ana. Not only that, but they do an excellent job of stocking heat. I saw Parlay, Toad Venom, and even All My Hats Are Dead on their shelves, as well as the aforementioned ‘It’s Lit’, and this next one as well! One of the big winners of the week was the Bud Professor, who took home first place for full melt in one of the more notorious of the 12 competitions that took place that week. While I’m not usually one to dab melt, this was one that I had to try in a banger, as well as nestled within the core of a joint. I’m not usually one to celebrate trophies, but this one absolutely deserved the acclaim. Its overwhelming aroma encompasses the room as soon as you crack the jar, and the flavor is even more enticing than the smell. I don’t know how to describe that sweet melon flavor better than that, other than to say it had an almost crystallized sugar taste in there too, and it was just exquisite.

https://hightimes.com/

Arizona Weed Sales Topped $1.4 Billion Last Year

Regulated sales of marijuana in Arizona topped $1.4 billion last year, according to state data, marking the third year in a row that licensed weed sales have exceeded $1 billion in the Grand Canyon State. Sales of recreational marijuana totaled more than $1 billion in 2023, while sales of medical cannabis brought in nearly $350 million, the Arizona Mirror reported on Tuesday. Arizona’s continued strong weed sales were welcome news for the state’s licensed cannabis businesses. Luke Flood, senior vice president and West regional leader for multistate operator Curaleaf, said, “Arizona has been a strong success story for us, and has become one of the top markets in the country for Curaleaf.”  “Since the launch of adult use, we have seen a lot of consolidation in the market on the retail side, along with a multitude of new third-party brands and products coming into the market, resulting in a wider selection for consumers at an affordable price,” Flood wrote in an emailed statement. “Uniquely, Arizona offers one of the lowest prices per gram at the retail level in the country.” Adult-use cannabis sales came to $1.1 billion in 2023, according to data from the Arizona Department of Revenue (ADOR), or about 72% of the year’s total sales. The year before, recreational marijuana sales contributed 70% of the yearly total. In 2021, the year adult-use cannabis sales began in Arizona, recreational weed made up only 45% of the state’s total cannabis market. “Reaching $1.4 billion in sales is a huge milestone for the state and I think it speaks to the wider efforts of de-stigmatization surrounding the plant,” Josh Hirschey, president of Arizona-based concentrate manufacturer Timeless, said in a statement. “The consumer demand for high-quality cannabis is there and Arizona brands are strategic in navigating natural limitations to normalize the plant,” he added. Monthly sales of recreational marijuana have totaled between about $80 million and $93.5 million since July 2022, peaking in March 2023 at $100 million. In January, adult-use sales dropped to $76.8 million, the first time in 18 months the figure was below $80 million. Medical cannabis sales totaled $348 million last year as the market for medicinal weed in Arizona continues to decline. Medical sales hit a monthly sales record of $73.4 million in April 2021 and have steadily decreased nearly every month since then. The decline in medicinal cannabis sales has coincided with a drop in the number of registered patients in Arizona’s medical marijuana program. Last month, the total number of medical marijuana cardholders was 111,168, down from the peak of 299,054. Arizona levies a 16% excise tax on adult-use cannabis sales in addition to the usual sales tax. Medical patients pay the sales tax of about 6%, depending on the area. Additionally, local jurisdictions add a tax of about 2% to all weed sales.  Last year, cannabis excise taxes totaled $172.8 million. Since recreational marijuana sales began in January 2021, the marijuana excise tax has generated $451 million in revenue for the state. Approximately one-third of Arizona’s marijuana tax revenue is earmarked for community college and provisional community college districts and 31% is dedicated to fire departments, fire districts, law enforcement and other first responders. One-fourth of state cannabis taxes are reserved for the Arizona Highway User Revenue Fund, while 10% is dedicated to the justice reinvestment fund supporting public health services, counseling, job training and other social services for communities that have been disproportionately affected by the War on Drugs. Although Arizona’s cannabis market has begun to stabilize, many of the state’s weed retailers are still optimistic about this year. Eivan Shahara, CEO of Mint Cannabis, said the business is “anticipating an even busier 2024, as we prepare to employ more people to serve more customers at our additional dispensary locations.” “The marijuana industry is blossoming into a significant job creator,” Shahara wrote in an email to High Times. “It’s estimated that the cannabis industry employs about 500,000 full-time equivalent positions in the U.S., with about 280 new jobs being added daily. This showcases a promising trend, as more than 100,000 new jobs were established in the previous year, making the cannabis industry one of America’s fastest-growing job sectors.”

https://hightimes.com/

California Cops Return Weed From Raid

The Los Angeles Times reported that “Costa Mesa police and city employees trucked more than 100 pounds of cannabis flower, boxes of oil cartridges and vaporizers along with documents, devices and security equipment held in police storage” to the owners of Se7enleaf, Michael Moussalli and Matteo Tabib, reached a settlement agreement with the city of Costa Mesa, California. According to the Times, Costa Mesa attorneys “had been mounting an offense against what they believed was illegal commerce taking place at the site.” “They didn’t like that they had to return the stuff,” Tabib told the Los Angeles Times. “They didn’t like that they were wrong, and they didn’t like that they were embarrassed and that nobody was charged. They gave no consideration that me and Michael and our employees’ lives are not in a good place right now.” As the newspaper noted, officials in the city are currently “undergoing a review of the city’s retail cannabis ordinance, considering amendments that would establish a buffer between dispensaries and residential properties and cut back on costly employee badge requirements.” Earlier this month, the Costa Mesa city council held an hours-long meeting where they considered possible changes to local laws regarding retail cannabis dispensaries.  As the Voice of OC reported at the time, the council is “looking to limit the number of retail cannabis shops to 35 after city officials began questioning just how many should operate within the city,” in addition to considering “how close the shops should sit next to homes, youth centers and other cannabis storefronts.” The Los Angeles Times reported that the members of the Costa Mesa city council “generally supported establishing a separation requirement of 250 feet between any new cannabis dispensaries and residentially zoned properties and 1,000 feet between storefronts and youth centers where children recreate.” “If passed, such a rule would make any already-approved shops inside that red zone ‘legal, nonconforming’ businesses. Although they may continue to operate in violation of the new rules, it’s not clear whether that status could hamper a property or business in the future,” the Times reported earlier this month. “The panel also agreed to process up to 35 cannabis business permits, to allow would-be operators who’ve already passed a pre-application stage to continue the process. After that, through attrition, a new citywide cap of 10 dispensaries could be instituted upon final approval. But because a cannabis business permit runs with an individual operator and may not be transferred if a dispensary is sold, it is unclear whether another owner would be able to apply for a new permit or be shut out by the cap.” Costa Mesa voters have twice passed ballot measures that have re-shaped the legal cannabis market in the city. Per Costa Mesa’s official website: “In 2016, Costa Mesa voters approved Measure X, known as the City of Costa Mesa Medical Marijuana Measure, which allows certain non-retail cannabis-uses (i.e. manufacturing, distribution, processing, transportation, research and development laboratories, and testing laboratories) in one industrial area of the City, commonly known as the “Green Zone.” In 2020, Costa Mesa voters approved Measure Q, the Costa Mesa Retail Cannabis Tax and Regulation Measure. This measure allows the City to adopt rules permitting retail cannabis uses within the City, including storefronts (dispensaries) and non-storefront uses (delivery only).” Those two measures figured prominently in the dispute between the city and Moussalli and Tabib, who are majority owners of High Seas Cannabis, a boutique dispensary in Costa Mesa. “Store owners had been waiting for a cannabis business permit, a final step delayed as city prosecutors and police processed the aftermath of the raid and an earlier inspection that discovered High Seas-branded product at a local cannabis delivery that had been co-packaged by Se7enleaf,” the Los Angeles Times explained last week. “Moussalli maintains the company was testing the marketplace ahead of the dispensary’s opening and not doing anything illegal. Since it opened in Costa Mesa after voters approved Measure X in 2016, Se7enleaf has engaged with the city’s chamber of commerce and even helped inform the 2020 retail cannabis ballot initiative Measure Q.” Moussalli told the newspaper that he and his partner are “still treated as the stepchildren of businesses in the city.”  “We just want the same basic opportunities and rights as businesses that are regulated in the same ways as ours, like liquor stores,” he said. “I’m concerned they’re going to impose more regulations on us that they don’t understand the consequences of,” he continued. “I just implore them to engage in more conversations with the industry, so we can avoid situations like the Se7enleaf/High Seas fiasco.”

https://hightimes.com/

Restaurant Denies Service to Rapper for Smelling Like Pot, Sparking National Debate in South Africa

Should restaurant patrons who smell like weed be denied service at a restaurant? That’s the question South Africans are asking after one of the country’s top rappers was denied service along with two friends.  South African rapper Emtee was denied service, along with two fellow rappers, from a branch of Mike’s Kitchen in Johannesburg, South Africa earlier this month after the restaurant complained that they smelled like weed. (Personal cannabis use at home is decriminalized and medical use is legal in South Africa.) The incident is prompting a national debate about the odor of cannabis in public spaces, and many people think the rappers were profiled as well. Emtee, who has millions of followers on Instagram, along with rappers Uncle Vinny and Yungseruno, said they were refused entry from Mike’s Kitchen in Parktown because they were “smelling of weed and had too many tattoos.” The restaurant chain is known for South African heritage-based dishes. TimesLIVE, South Africa’s second-biggest news website, reports that Emtee’s lawyers demanded an apology from Mike’s Heritage House in the upscale Parktown neighborhood of Johannesburg or he will take legal action against the restaurant. “We decided to go have lunch at Mikes Kitchen, Parktown,” Emtee said. “We were dropped off. We walked in and as we were being ushered to our table, a white man comes and tells us to leave because we ‘smell of weed and we had too many tattoos’. Mind you, our transport has left. This ho ass nigga kicked out the yard,” Emtee said. While apartheid ended decades ago, a severe case of race inequality remains rampant in Johannesburg, with nearly 40% of Black South Africans unemployed, a much higher ratio than their white counterparts. South African leaders, however, are currently taking measures to promote equity. On April 12, 2023, South African President Cyril Ramaphosa signed into law the Employment Equity Amendment Bill of 2020, which enacts “equity targets” to promote equity in the business sector. Emtee sounded fed up after being denied entry from the restaurant, suggesting racism was at play as well. “Fuck Mikes Kitchen in Parktown!” Emtee said. “You are about to get served. The fuck!? Fuck y’all food! At this, you are all fucking with me and my guys for nothing. Talking about ‘I’m gonna call the police’, call them! Scary ass bitch. Say never go to Mikes Kitchen Parktown. The son of biches is racist! Yeah I said! You all gone have to kill me. Mikes kitchen in Park Town is going down!” Emtee’s legal representatives have demanded that Mike’s Kitchen issue a public apology on Wednesday to the star or they will proceed with legal action. Mike’s Kitchen publicist Melinda Shore told TimesLIVE, “We are handling this privately. It’s not a matter they want to handle in the media. It’s being handled and taken seriously.” Emtee responded by posting a video on Instagram of himself buying a bottle of cologne, probably referring to the Mike’s Kitchen incident. “They say I’m this, they say I’m that,” Emtee posted on Instagram. “They forgot to tell you I smell best. When you see, embrace me.” “My life isn’t easy but I woke up feeling blessed,” Emtee sings on his latest single. “Smokin’ on that zaza, tryna balance out the stress…” In the U.S. the E-Bar restaurant in Dallas, Texas also discriminates against and denies service to patrons if they smell like weed. Last November, the South African National Assembly approved a bill that would decrminalize the personal use of cannabis. The Cannabis for Private Purposes Bill has been in the works since the country decriminalized private cannabis use in 2018 and now heads to the National Council of Provinces for concurrence. While it’s legal at home, it’s still illegal to smoke outside of one’s private dwelling, and it’s also illegal to buy or sell cannabis. Medical cannabis may also be prescribed. Democratic Alliance Member of Parliament Janho Engelbrecht spoke about the bill in the National Assembly, highlighting adults will only be allowed to use cannabis privately in their homes and sales will still be strictly prohibited should the measure pass. “People should bear in mind what this bill is about. It is about cannabis for private use by adults. You are not allowed to buy or sell cannabis, because this still remains a criminal activity with severe consequences. If you want to smoke it, you have to grow it, don’t buy it,” Engelbrecht said. Despite decriminalization and medical cannabis in the country, South Africa still is in need of change.

https://hightimes.com/

Gavin Rossdale Shows How Celebrity Weed Features Should Be Done

Since breaking through with Sixteen Stone in 1994, Bush’s Gavin Rossdale has been a music industry mainstay. The debut album peaked at #4 on the Billboard charts, leading to successful albums and side projects over the next three decades. In all, Rossdale and Bush have amassed 24 million record sales and over a billion streams.  The band’s debut release, known for hits like “Machinehead” and “Glycerine,” solidified Bush’s 90s legacy. They continued with chart-topping releases, including 1996’s follow-up Razorblade Suitcase, and maintained momentum through the 2000s. Their latest album, The Art of Survival, released in 2022.  The combined endeavors created a lasting impact in the ears and minds of listeners, amassing 24 million records sold and over a billion streams across various platforms. With Gen-Z leading a 90s revival in recent years, the band has earned scores more fans while reminding older listeners that unlike some 90s acts, Bush isn’t a nostalgia act.  That’s great and all, but why are we talking about this in a weed publication? Great question! It all boils down to authenticity. Gavin Rossdale’s eager engagement with New York’s weed culture, exploring both licensed and unlicensed scenes, stands out in the saturated world of celebrity weed narratives that few others have been willing to embark on. In doing so, he created a lasting experience for himself and hopefully readers.  We introduced Rossdale to New York’s licensed cannabis scene with a stop at The Travel Agency in Union Square, a sleek, all-white interior dispensary with discreet marketing, thanks to state laws. Despite its unassuming street presence, marked only by a small sign above eye level, a joint-styled art installation in the window lets passersby know what’s inside. Rossdale mentioned previously visiting one of the city’s untold number of unlicensed shops in the city. He discussed how the shop gave off a lack of trust and fostered shopper uncertainty about product quality and trust.  “You’re just basically buying it old school from some dude on the corner,” he remarked. Rossdale felt similarly uncertain about licensed shop products, likely due to his unfamiliarity with many of the brands sold in the store and an inability to smell flower.  However, he took a keen interest in learning. Photographer Jhalil D. Wright and I peppered Rossdale with facts about the market, products, and particular brands. Typically, this type of info dump leads many to tune out or lose interest. To the singer’s credit, he soaked up the information, showing an eagerness to learn about topics like market trust, sprayed terps, and drying and curing methods. While shopping, the Bush frontman discussed his preference for smoking flower and largely avoiding pre-rolls. After browsing for a few minutes, Rossdale bought an eighth of Mimosa from Etain despite the restrictions on examining product before buying. He also scooped up edibles from Eaton Botanticals, infused olive oil from Chef for Higher, and Flintts Mints. The experience was fine enough, or at least as much as a shop can deliver under New York law. But, like many legacy consumers, Rossdale seemed to be seeking something more hands-on. To get that, we visited the underground hotspot Astor Club.  On the ride over, Rossdale discussed his preferences for weed over alcohol, stating that drinking and hangovers do not benefit singers while on tour. No matter the substance, Rossdale likes to remember that it should amplify the moment or intention, not bring someone down. He’s shared this with his three sons under-18.  He emphasized the importance of telling them the truth. “Use it to amplify the moment instead of pull you down,” he explained. “My main thing is just to be a guy, to be helpful, not a hypocrite,” he said, noting that pot makes him feel creative. To maintain the effects to his ideal level, Rossdale tends to consume every few days.  At Astor Club, Rossdale found the cannabis experience he was looking for. No shade to The Travel Agency or any other licensed spot. It’s not their fault. The current state and federal regulations don’t allow dispensaries to compete with the flower or features found at underground meccas. On the other hand, Astor Club has cultivated a reputation for sourcing the top bud from elite producers across the country—all while creating an environment synonymous with the culture.  After rolling up a J of Cookie Dough from Khashtree Mason, Rossdale was convinced. “It’s like Cristal Champagne,” he said, offering ample praise for the bud and the lounge. The Bush founder was so fond of the strain that he almost stuck to it exclusively. Staff ended up reminding him of their extensive menu, all top tier options in their own right. Eventually, a few different strains were selected and smoked.   After smoking another J, Rossdale discussed his career and personal life in-depth. Feeling that living with intention, learning, and striving to improve are all important, he said, “You have to put everything into it.” As evidenced by Bush’s new harder rock and detuned sound, Rossdale said he loves finding new sounds and ways to play music, as evidenced by the detuned sound on the band’s 2022 album The Art of Survival.  A greatest hits album, Loaded, was released in October 2023. Originally hesitant to put out a hits compilation and be seen as a fading act, Rossdale is now eager to see the band’s top works compiled together.  “It’s been really fun to look back and see what those songs have done for other people,” Rossdale said, sharing a similar feeling when playing live. “When I play those big crowds, it’s really fun, because there’s all these memories emanating like shooting stars out of all the audiences.” The band embarks on a summer tour starting June 1.  Despite the ongoing passion for music and performing, Rossdale does see retirement happening at some point. A self-proclaimed fan of restaurants and food, he recently put his passion on screen hosting his own celebrity cooking show, Rockstar Kitchen Chronicles, featuring guests such as Tom Jones and Jack McBrayer.  Despite a love for food, music, the plant, and more, Rossdale envisions dogs as his ideal next career. “I would like to run a huge ranch for rescue dogs and animals,” he said.  Enamored with the menu of choices, Rossdale, Jhalil and I departed Astor Club with a few more selections, including more Cookie Dough and Moon Doh from Archive.  Credit to Rossdale and his public relations team. All too often, PR will pitch Zoom interviews and carefully curated celebrity press ops that blanket numerous outlets and reporters, often regurgitating the same talking points no matter the outlet.  After years of writing up celeb features that didn’t do much for the plant or reader, I have chosen to steer clear of most star-studded coverage, especially those making the media rounds hawking their new seeds, strain, brand, etc. Rossdale was no doubt in press mode, promoting his new tour and latest single. But unlike far too many celebrities, he didn’t have a stake in the weed game. He just wanted to pick up, smoke, and talk shop.  This simple, authentic concept is one few outside of hip hop have even flirted with on the record. And that’s a damn shame. The standard media approach does little for readers and, as sales seem to indicate, it does little to help most brands boost sales or awareness. Rather than Zoom-ing or calling it to discuss a fondness for weed, Rossdale showed up, discussed his own experiences, and demonstrated an authentic desire to learn more. In doing so, he got to see both sides of New York City’s weed community, and got hella high in the process. And, unless I fucked up in my role as the storyteller here, the Rossdale approach makes for a better story every time. 

https://hightimes.com/

Mexican President Says Country Won’t Combat Cartels on Orders From U.S.

At a conference last week, Andrés Manuel López Obrador, Mexico’s president since 2018, said, “We are not going to act as policemen for any foreign government,” as quoted by the Associated Press. “Mexico First. Our home comes first.” As the Associated Press noted, López Obrador has, in previous years, “laid out various justifications for his ‘hugs, not bullets’ policy of avoiding clashes with the cartels.”  “In the past he has said ‘you cannot fight violence with violence,’ and on other occasions he has argued the government has to address ‘the causes’ of drug cartel violence, ascribing them to poverty or a lack of opportunities,” the AP reported, adding that “López Obrador’s view — like many of his policies — harkens back to the 1970s, a period when many officials believed that Mexican cartels selling drugs to gringos was a U.S. issue, not a Mexican one.” On Friday, the president “basically argued that drugs were a U.S. problem, not a Mexican one,” and he “offered to help limit the flow of drugs into the United States, but only, he said, on humanitarian grounds,” according to the Associated Press. “Of course we are going to cooperate in fighting drugs, above all because it has become a very sensitive, very sad humanitarian issue, because a lot of young people are dying in the United States because of fentanyl,” the president said. Over 70,000 Americans die annually because of synthetic opioids like fentanyl, which are mainly made in Mexico from precursor chemicals smuggled in from China,” López Obrador said. In February, The New York Times reported that United States “law enforcement officials spent years looking into allegations that allies of” López Obrador “met with and took millions of dollars from drug cartels after he took office.” The Times, citing U.S. records and three people familiar with the matter, said that the previously unreported inquiry “uncovered information pointing to potential links between powerful cartel operatives and Mexican advisers and officials close to the president while he governed the country.” “But the United States never opened a formal investigation into Mr. López Obrador, and the officials involved ultimately shelved the inquiry. They concluded that the U.S. government had little appetite to pursue allegations against the leader of one of America’s top allies, said the three people familiar with the case, who were not authorized to speak publicly,” the Times reported at the time. More from the Times’ report at the time: “Much of the information collected by U.S. officials came from informants whose accounts can be difficult to corroborate and sometimes end up being incorrect. The investigators obtained the information while looking into the activities of drug cartels, and it was not clear how much of what the informants told them was independently confirmed. For example, records show that the investigators were told by an informant that one of Mr. López Obrador’s closest confidants met with Ismael Zambada García, a top leader of the Sinaloa drug cartel, before his victory in the 2018 presidential election. A different source told them that after the president was elected, a founder of the notoriously violent Zetas cartel paid $4 million to two of Mr. López Obrador’s allies in the hope of being released from prison. Investigators obtained information from a third source suggesting that drug cartels were in possession of videos of the president’s sons picking up drug money, records show.” López Obrador, responding to The New York Times’ reporting, vehemently denied the allegations and called on the United States to clear up the matter. “It’s all completely false,” López Obrador said in February. “The U.S. government is going to have to address this.” He even suggested that the report could damage Mexico’s relationship with the U.S. “Does this diminish the trust the Mexican government has in the United States?” Mr. López Obrador said, as quoted by the Times. “Time will tell.” A spokesperson for the U.S. Department of Justice said there was no investigation into the Mexican president at the time. The Associated Press, in its report on Lopez Obrador’s latest comments, has a rundown on his relatively lax view toward the cartels: “López Obrador has argued before against ‘demonizing’ the drug cartels, and has encouraged leaders of the Catholic church to try to negotiate peace pacts between warring gangs. Explaining why he has ordered the army not to attack cartel gunmen, López Obrador said in 2022 ‘we also take care of the lives of the gang members, they are human beings.’ He has also sometimes appeared not to take the violence issue seriously. In June 2023, he said of one drug gang that had abducted 14 police officers: ‘I’m going to tell on you to your fathers and grandfathers,’ suggesting they should get a good spanking. Asked about those comments at the time, residents of one town in the western Mexico state of Michoacan who have lived under drug cartel control for years reacted with disgust and disbelief.”

https://hightimes.com/

Minnesota Bill Doubles Home Grow Plant Count for MMJ Patients

Medical marijuana patients would be permitted to grow up to 16 cannabis plants at home under a bill now pending in the state legislature. If approved, patients and caregivers would be able to grow twice the number of plants allowed under the state’s recreational marijuana legalization law, which went into effect on August 1 of last year. Minnesota legalized medical marijuana in 2014 with a law that allows patients diagnosed with certain qualifying conditions to use cannabis medicinally with a doctor’s recommendation. The law also allows the state’s approximately 41,000 registered patients to designate a caregiver to pick up medical marijuana from a licensed medical dispensary on their behalf. The law did not authorize home cultivation by patients or caregivers, however. The recreational marijuana legalization bill passed last year allows adults to grow up to eight cannabis plants at home, including up to four mature plants. Under a bill (HF 3766) introduced by Democratic Representative Jessica Hanson earlier this month, registered medical cannabis patients would be permitted to grow 16 plants. The bill also allows registered caregivers to grow marijuana on a patient’s behalf. At a hearing on the legislation on Monday, Hanson said the bill would allow more medical marijuana patients to benefit from homegrown cannabis. She noted that because of their medical conditions, many patients have limited incomes that do not allow them to buy medical marijuana at dispensary prices. Additionally, patients who are disabled or face other limitations often are not able to grow cannabis themselves. “As it stands, people with disabilities and conditions that qualify them to be on the medical program can only grow their own if they know how to, if they can afford to, if their condition or living situation allows them to or if they know someone who will gift them homegrown products,” Hanson said, according to a report from CBS News. Hanson told her colleagues that approving the bill would allow more patients to take advantage of the state’s medical cannabis program. “We do not think that people with qualifying medical conditions on our medical cannabis program ought to be left out of the ability to benefit from homegrown cannabis simply because they are unable to grow it by themselves,” Hanson said in a news report of the hearing published by the Minnesota House of Representatives. Republican state Representative Anne Neu Brindley questioned the need for Hanson’s bill, noting that the recreational marijuana legalization law allows all adults to grow cannabis at home. She also noted that cannabis grown under Hanson’s bill would not face the same safety testing requirements faced by commercial cannabis growers. “I would question whether or not caregivers are the best place to do that. They’re not trained in this and we’re treating this as medicine in this situation particularly,” she said. “And so I would question whether or not this is the most appropriate way to move forward on that.” Hanson replied that the cannabis lab testing infrastructure in Minnesota would not be able to accommodate the demand that would be created by requiring all homegrown medical cannabis to be tested. She also noted that the law does not require testing of home-cultivated recreational marijuana. “It’s my opinion that setting a different or a higher bar for people with disabilities who simply need help growing their own cannabis at home is not inclusive,” Hanson said. Leili Fatehi, a cannabis advocate and partner and principal of Minneapolis-based consultancy firm Blunt Strategies, said that the “legislation takes a thoughtful approach to the complex issues faced by patients with debilitating conditions, aiming to reduce the financial burden associated with accessing effective treatment.” “The efforts of Rep. Jessica Hanson and local advocates highlight a commitment to compassionate, patient-centered healthcare, reflecting the best in both legislative and community leadership,” Fatehi wrote in a statement to High Times. “Moreover, recognizing that many in our registry program are either physically incapable of cultivating cannabis due to health conditions or are hindered by their living situations, this bill addresses the critical need for accessible alternatives to forcing patients to choose between high dispensary prices or the unpredictability of receiving cannabis through legal gifting.” Hanson’s bill has been referred to the House Commerce Finance and Policy Committee for consideration.

https://hightimes.com/

Cannabis Cultivator Fees Waived in New York Until 2026

The New York State Cannabis Control Board (CCB) recently voted to waive cannabis cultivator licensing fees for the next two years. Gov. Kathy Hochul celebrated this recent progress to help struggling cultivators. “Farmers are the backbone of our State, and we’re making sure the family farms across New York that are building our cannabis industry have a real chance to succeed,” Hochul said. “I have made it clear that New York State needs to issue more dispensary licenses and kickstart cannabis sales in New York, and this two-year promise to Adult-Use Conditional Cultivators will make sure these farmers can reap the benefits of this growing industry.” On the same day, the CCB also approved 114 new cannabis business licenses (45 for retail dispensaries and 31 microbusinesses) which allows the grantees to grow, process, and sell cannabis. The state currently has 89 licensed dispensaries currently operating, and hundreds more licenses that have been granted, with 223 approved in 2024. Additionally, the CCB approved 38 non-conditional adult-use licenses as well.  Until 2026, cultivators will no longer have to pay for the fee that is applied when they transition to a non-conditional license, such as cultivation or microbusiness licenses. Conditional license fees range anywhere between $4,500 to $40,000, and the price is based on their license tier size and canopy size, according to a press release published by Hochul’s office. Chris Alexander, executive director of the New York Office of Cannabis Management also provided a statement regarding the new licenses. “New York State’s cannabis market is moving in the right direction, and by waiving licensing fees for two years, we’re making sure conditional cultivators have a chance to reap the rewards of this growing industry,” Alexander said. “As we mark three years of legalized adult-use cannabis in New York state, we look forward to this next chapter of our cannabis story.” The 114 applicants who were granted licenses on March 22 submitted their applications prior to Nov. 17, 2023, and also already own a physical location for their business. Those who applied after Nov. 17 but before Dec. 18 will likely be approved within the next few months “on a rolling basis.” At the March meeting, the CCB also renewed permits for 17 testing labs. “Since the last Cannabis Control Board meeting in February, 16 new adult-use cannabis dispensaries have opened their doors across New York State,” the CCB wrote in a press release. “This is a continuation of the swift rate of store openings since the December lifting of an injunction preventing New York’s retail cannabis licensees from opening their doors.” There are an estimated 2,000 illegal cannabis business operators in New York, according to The New York Times. In comparison to the 89 legal businesses (10 which are delivery-only), that is approximately 24 illegal businesses for every one legal business. The original legal framework for New York’s adult-use cannabis program was signed by former Gov. Andrew Cuomo in March 2021, and Hochul replaced him and took office later that year in August. Last month Hochul spoke about the initial framework. “You have to go back to the very beginning,” Hochul said. “Prior to my time [as governor], the legislation was crafted in a way that was not poised for success.” As a result though, legal cannabis businesses have been struggling. “We’ve got farmers who are just losing money. We’ve got these people who took out loans and are excited about their opportunities, ready to start,” Hochul said. “And meanwhile, no money is flowing back to the state. We have all this, and the illicit market is flourishing.” Earlier this month, the New York Senate discussed a budget proposal that would earmark $128 million to support cannabis businesses. This includes $60 million to go toward farmers’ loans, $40 million for Cannabis Farmer Relief Fund grants, and $28 million for cannabis farmers who lost money due to the state’s slow ramp-up for its legal industry. A few weeks ago on the Senate floor, Sen. George Borrello spoke about the importance of the bill. “We are now three years into where we have passed the legalization of recreational marijuana in New York state—three years now this month,” said Borrello, according to The Post-Journal. “We are now proposing a bailout for pot farmers of $128 million. We all, I think, would agree this has been an abject failure. It’s been said on both sides of the aisle. Somehow New York state has managed to screw up pot. I don’t know how that happens, but we did.” Sen. Michelle Hinchey proposed a bill last year that was ultimately vetoed by Hochul but would have opened up opportunities for cannabis farmers earlier. “I don’t right now have any numbers on the broader spectrum of cannabis across the state, but I think it’s incredibly important to recognize and acknowledge that these are growers who we asked to grow the product for the market and so the $128 million here is to cover the losses they would have seen since the rollout was delayed and making sure they have the funds to be able to stay in business until the next growing cycle,” Hinchey explained.

https://hightimes.com/

Recreational Rapper Weed: The Rick Ross Interview

Rap music and cannabis are a marriage crafted in heaven, or hell depending on where your God lines up on the whole “getting high” thing. With the uprising of recreational cannabis has come a plethora of celebrity strain releases. Some of them were obvious marketing ploys with no real foresight or follow through when it came to the actual weed being sold. Some of these collaborations, however, have been met with overwhelming positivity when it comes to the community response. If anyone remembers the Tenco Pink Zushi collab with Coi Leray, or the Knockout OG release from Mike Tyson’s brand, the general consensus on both was that it was fire flower with a big name behind it to fuel sales. In other words, when done correctly, celebrity rec weed can be a win-win for everybody involved. Rick Ross, the rapper and millionaire teamed up with a Los Angeles-based brand called High Tolerance to bring his own line of celebrity flower to market. High Times had the opportunity to catch up with the boss himself and the High Tolerance guys to find out more about this collaboration and the strains they released, some of which also include collaborations with fellow rappers Jim Jones and Rich the Kid. High Times: What has cannabis done for you, your life, your career as a rapper?   Rick Ross: Cannabis has helped me create the music because it’s always put me in the zone. High Times: What does your strain, Collins Ave, make you feel like?  Rick Ross: It makes me feel like a Boss. It’s very uplifting, gets my vibes right. It gets me in the place I like. High Times: What does it taste like?  Rick Ross: Real sweet, gassy. It’s the finest flower. High Times: How do you like to consume it (blunts, joints, bongs etc)?  Rick Ross: Recently I’ve been doing the big joint in my new venture. I’ve been doing a couple bong rips. High Times: Do you write and/or record your raps high?  Rick Ross: I’m always smoking that High Tolerance. I have a high tolerance. It helps me stay creative. It’s a big part of my music and my everyday life.  High Times: Does this help the creative process in your experience?  Rick Ross: Most definitely. High Tolerance gets me relaxed and focused at the same time and in the zone vibing. High Times: What made you decide to bring Rich the Kid and Jim Jones in on this collaboration? What do they bring to the table for this experience you’re providing to people? Rick Ross: I didn’t bring em but Manny the CEO is heavy in the culture. Everybody knows that High Tolerance got the finest flower and it was just natural for them to want their own collab. That’s what they do. High Times: Why did you choose High Tolerance to create this strain with?  Rick Ross: High Tolerance has the finest flower and they’re the best in the game right now. Both on the East and West coasts. That’s the top shelf weed that real weed connoisseurs like. High Times: Anything I didn’t ask you’d like to talk about in connection with this collaboration?  Rick Ross: We dropped Collins [Ave] and everyone loved it so much we had to come back with more so we dropped Boss Pop and Belair Pop. You guys can find it in dispensaries in Los Angeles everywhere. Stay tuned for some new stuff coming and new limited merch drops. This might not be super common knowledge but before he was a rapper, Rick Ross spent a little over a year as a correctional officer. He talked about it on an episode of the Full Send podcast in March of 2022. The hosts of the podcast asked if he enjoyed the work and he said he was not a fan. “I didn’t. Anything you gotta really do you’re fuckin’ running, jogging and all of that shit man,” Rick Ross said to the hosts of Full Send. High Times asked specifically if Rick Ross worked with cannabis prisoners in his experience as a correctional officer and if this experience had anything to do with his venture into the cannabis industry. Unfortunately, Rick Ross declined to comment on this. As far as the weed itself and the producers behind it, High Tolerance CEO Manny enlightened us a bit on the process that went into choosing the strain to be used for Collins Ave, which he said was a Gelato X Biscotti cross that came out a bit heavier on the Gelato side. Manny said that when he and Rick Ross decided to collaborate, he brought the rapper five to seven samples to try so he could pick his favorites which became Collins Ave, Boss Pop and Belair Pop. The High Tolerance CEO also gifted Rick Ross with a chain and ring to celebrate their collaboration which TMZ estimated to be worth around $130K together. “I brought him a good five to seven samples and he ended up liking two or three of them, which is how we ended up coming out with more than just one color, one strain for him because he really liked a couple flavors,” Manny said. “So we gave him Collins Ave. which was his idea, then we came out with the Boss Pop. We have a whole line of pops with a whole bunch of our celebrity collabs. Then we also did the Belair Pop.” Manny told me he smokes with Rick Ross whenever he sees him. Given the name of the company, High Tolerance, I had to ask Manny who had the Higher Tolerance between him and Rick Ross. “I think I still take the vote for that,” Manny said. “Just because I do concentrates and stuff but he really doesn’t do that.” Manny said that High Tolerance has some other projects in the works that the people should keep an eye out for. They’re coming out with a tobacco line including leaf wraps, cigars, grabba and whole leaf. They have more celebrity collaboration strains in the works, the specifics of which he could not share with me just yet, but from what he teased it’s some pretty big names involved. They’re also launching a line of flower called Fly Girl Flower which will be in collectible packaging that resembles Birkin Bags. On top of all that, High Tolerance is getting into the music business, a natural transition given the number of cannabis collaborations they have with rappers. As aforementioned, one of those collaborations is with Jim Jones. Manny said High Tolerance Records is releasing a song by the artist Low Key featuring Jim Jones. Other artists signed to High Tolerance records include Ace, Killa Brand and Yomel.

FAQ: How to use this hemp news hub

What topics does Chow420’s hemp news cover?

We aggregate and surface reputable coverage on hemp laws and enforcement, THC thresholds and policy proposals, cannabinoid products (CBD/Delta-8/hemp-derived THC), compliance, lab testing, recalls, and broader industry news.

Is this legal advice?

No. This page is for news and education. Hemp rules can change quickly and vary by state—always verify against the latest official guidance and consult qualified counsel for compliance decisions.

How do I evaluate hemp product safety claims?

Look for current third‑party COAs (Certificates of Analysis), clear ingredient labeling, and transparent sourcing. Be cautious with vague potency claims or missing lab reports.

Why do some articles mention Delta‑8 or “hemp-derived THC”?

These products often sit at the center of policy and enforcement changes. We track major updates so shoppers and brands can understand evolving requirements and market impacts.

How often is the news updated?

The crawler is scheduled to run daily. New items appear as sources publish updates.